Fig. 7From: Therapeutic effects of Lucilia sericata larval excretion/secretion products on Leishmania major under in vitro and in vivo conditionsProgression of leishmanial lesion size in treated and control BALB/c mice from pre-intervention stages until the 8th week post-treatment (differences are considered statistically significant at P < 0.05; ****P < 0.001)Back to article page